A QRS scoring system for assessing left ventricular function after myocardial infarction. Palmeri ST, Harrison DG, Cobb FR, Morris KG, Harrell FE, Ideker RE, Selvester RH, Wagner GS (1982) N Engl J Med 306: 4-9 Percent emphysema, airflow obstruction, and impaired left ventricular filling. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE (2010) N Engl J Med 362: 217-27 Need for Multidisciplinary Research and Data-Driven Guidelines for the Cardiovascular Care of Patients With Cancer. Meijers WC, Moslehi JJ (2019) JAMA 322: 1775-1776 The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. Califf RM, Harrell FE, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN, Pryor DB (1989) JAMA 261: 2077-86 Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. Traverse JH, Henry TD, Ellis SG, Pepine CJ, Willerson JT, Zhao DX, Forder JR, Byrne BJ, Hatzopoulos AK, Penn MS, Perin EC, Baran KW, Chambers J, Lambert C, Raveendran G, Simon DI, Vaughan DE, Simpson LM, Gee AP, Taylor DA, Cogle CR, Thomas JD, Silva GV, Jorgenson BC, Olson RE, Bowman S, Francescon J, Geither C, Handberg E, Smith DX, Baraniuk S, Piller LB, Loghin C, Aguilar D, Richman S, Zierold C, Bettencourt J, Sayre SL, Vojvodic RW, Skarlatos SI, Gordon DJ, Ebert RF, Kwak M, Moyé LA, Simari RD, Cardiovascular Cell Therapy ResearchNetwork (2011) JAMA 306: 2110-9 Left ventricular pressure-volume and Frank-Starling relations in endurance athletes. Implications for orthostatic tolerance and exercise performance. Levine BD, Lane LD, Buckey JC, Friedman DB, Blomqvist CG (1991) Circulation 84: 1016-23 Survival of coronary artery disease patients with stable pain and normal left ventricular function treated medically or surgically at Duke University. Whalen RE, Harrell FE, Lee KL, Rosati RA (1982) Circulation 65: 49-52 Natural history of asymptomatic left ventricular systolic dysfunction in the community. Wang TJ, Evans JC, Benjamin EJ, Levy D, LeRoy EC, Vasan RS (2003) Circulation 108: 977-82 Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute. Lee DS, Gona P, Vasan RS, Larson MG, Benjamin EJ, Wang TJ, Tu JV, Levy D (2009) Circulation 119: 3070-7 The use of radionuclide angiography in the diagnosis of coronary artery disease--a logistic regression analysis. Gibbons RJ, Lee KL, Pryor D, Harrell FE, Coleman RE, Cobb FR, Rosati RA, Jones RH (1983) Circulation 68: 740-6 Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition. Hubers SA, Brown NJ (2016) Circulation 133: 1115-24 Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. Gupta DK, Shah AM, Giugliano RP, Ruff CT, Antman EM, Grip LT, Deenadayalu N, Hoffman E, Patel I, Shi M, Mercuri M, Mitrovic V, Braunwald E, Solomon SD, Effective aNticoaGulation with factor xA next GEneration in AF-Thrombolysis In Myocardial Infarction 48 Echocardiographic Study Investigators (2014) Eur Heart J 35: 1457-65 Regression of "gray zone" exercise-induced concentric left ventricular hypertrophy during prescribed detraining. Weiner RB, Wang F, Berkstresser B, Kim J, Wang TJ, Lewis GD, Hutter AM, Picard MH, Baggish AL (2012) J Am Coll Cardiol 59: 1992-4 Impaired systolic function by strain imaging in heart failure with preserved ejection fraction. Kraigher-Krainer E, Shah AM, Gupta DK, Santos A, Claggett B, Pieske B, Zile MR, Voors AA, Lefkowitz MP, Packer M, McMurray JJ, Solomon SD, PARAMOUNT Investigators (2014) J Am Coll Cardiol 63: 447-56 Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease. Califf RM, Mark DB, Harrell FE, Hlatky MA, Lee KL, Rosati RA, Pryor DB (1988) J Am Coll Cardiol 11: 20-6 Prediction of cardiac events in patients with reduced left ventricular ejection fraction with dobutamine cardiovascular magnetic resonance assessment of wall motion score index. Dall'Armellina E, Morgan TM, Mandapaka S, Ntim W, Carr JJ, Hamilton CA, Hoyle J, Clark H, Clark P, Link KM, Case D, Hundley WG (2008) J Am Coll Cardiol 52: 279-86 Emergency coronary artery bypass surgery for percutaneous coronary interventions: changes in the incidence, clinical characteristics, and indications from 1979 to 2003. Yang EH, Gumina RJ, Lennon RJ, Holmes DR, Rihal CS, Singh M (2005) J Am Coll Cardiol 46: 2004-9 Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling. Bhushan S, Kondo K, Polhemus DJ, Otsuka H, Nicholson CK, Tao YX, Huang H, Georgiopoulou VV, Murohara T, Calvert JW, Butler J, Lefer DJ (2014) Circ Res 114: 1281-91 Mice lacking inducible nitric oxide synthase have improved left ventricular contractile function and reduced apoptotic cell death late after myocardial infarction. Sam F, Sawyer DB, Xie Z, Chang DL, Ngoy S, Brenner DA, Siwik DA, Singh K, Apstein CS, Colucci WS (2001) Circ Res 89: 351-6 Prognostic importance of pathophysiologic markers in patients with heart failure and preserved ejection fraction. Burke MA, Katz DH, Beussink L, Selvaraj S, Gupta DK, Fox J, Chakrabarti S, Sauer AJ, Rich JD, Freed BH, Shah SJ (2014) Circ Heart Fail 7: 288-99 Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial. Palardy M, Stevenson LW, Tasissa G, Hamilton MA, Bourge RC, Disalvo TG, Elkayam U, Hill JA, Reimold SC, ESCAPE Investigators (2009) Circ Heart Fail 2: 181-8 Effect of acute arteriolar vasodilation on capacitance and resistance in pulmonary arterial hypertension. Newman JH, Brittain EL, Robbins IM, Hemnes AR (2015) Chest 147: 1080-1085 Sex-specific cardiovascular structure and function in heart failure with preserved ejection fraction. Gori M, Lam CS, Gupta DK, Santos AB, Cheng S, Shah AM, Claggett B, Zile MR, Kraigher-Krainer E, Pieske B, Voors AA, Packer M, Bransford T, Lefkowitz M, McMurray JJ, Solomon SD, PARAMOUNT Investigators (2014) Eur J Heart Fail 16: 535-42 Effects of treatment recommendations and specialist intervention on care provided by primary care physicians to patients with myocardial infarction or heart failure. Guadagnoli E, Normand SL, DiSalvo TG, Palmer RH, McNeil BJ (2004) Am J Med 117: 371-9 A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST). Califf RM, Adams KF, McKenna WJ, Gheorghiade M, Uretsky BF, McNulty SE, Darius H, Schulman K, Zannad F, Handberg-Thurmond E, Harrell FE, Wheeler W, Soler-Soler J, Swedberg K (1997) Am Heart J 134: 44-54 Increased myocardial native T1 and extracellular volume in patients with Duchenne muscular dystrophy. Soslow JH, Damon SM, Crum K, Lawson MA, Slaughter JC, Xu M, Arai AE, Sawyer DB, Parra DA, Damon BM, Markham LW (2016) J Cardiovasc Magn Reson 18: 5 The impact of isometric handgrip testing on left ventricular twist mechanics. Weiner RB, Weyman AE, Kim JH, Wang TJ, Picard MH, Baggish AL (2012) J Physiol 590: 5141-50 Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Hughey CC, Ma L, James FD, Bracy DP, Wang Z, Wasserman DH, Rottman JN, Hittel DS, Shearer J (2013) Cardiovasc Diabetol 12: 128 Do optimal prognostic thresholds in continuous physiological variables really exist? Analysis of origin of apparent thresholds, with systematic review for peak oxygen consumption, ejection fraction and BNP. Giannoni A, Baruah R, Leong T, Rehman MB, Pastormerlo LE, Harrell FE, Coats AJ, Francis DP (2014) PLoS One 9: e81699 The continuing evolution of the Langendorff and ejecting murine heart: new advances in cardiac phenotyping. Liao R, Podesser BK, Lim CC (2012) Am J Physiol Heart Circ Physiol 303: H156-67 Genome-wide association and pathway analysis of left ventricular function after anthracycline exposure in adults. Wells QS, Veatch OJ, Fessel JP, Joon AY, Levinson RT, Mosley JD, Held EP, Lindsay CS, Shaffer CM, Weeke PE, Glazer AM, Bersell KR, Van Driest SL, Karnes JH, Blair MA, Lagrone LW, Su YR, Bowton EA, Feng Z, Ky B, Lenihan DJ, Fisch MJ, Denny JC, Roden DM (2017) Pharmacogenet Genomics 27: 247-254 Minimally invasive fibrillating mitral valve replacement for patients with advanced cardiomyopathy: a safe and effective approach to treat a complex problem. Brittain EL, Goyal SK, Sample MA, Leacche M, Absi TS, Papa F, Churchwell KB, Ball S, Byrne JG, Maltais S, Petracek MR, Mendes L (2014) J Thorac Cardiovasc Surg 148: 2045-2051.e1 Prognosis of Low Normal Left Ventricular Ejection Fraction in an Asymptomatic Population-Based Adult Cohort: The Multiethnic Study of Atherosclerosis. Yeboah J, Rodriguez CJ, Qureshi W, Liu S, Carr JJ, Lima JA, Hundley WG, Herrington DM (2016) J Card Fail 22: 763-8 Circulating neuregulin during the transition from stage A to stage B/C heart failure in a breast cancer cohort. Geisberg CA, Abdallah WM, da Silva M, Silverstein C, Smith HM, Abramson V, Mayer I, Means-Powell J, Freehardt D, White B, Lenihan D, Sawyer DB (2013) J Card Fail 19: 10-5 Cardiovascular effects of vasoactive intestinal peptide in healthy subjects. Frase LL, Gaffney FA, Lane LD, Buckey JC, Said SI, Blomqvist CG, Krejs GJ (1987) Am J Cardiol 60: 1356-61 Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction. Velagaleti RS, Gona P, Pencina MJ, Aragam J, Wang TJ, Levy D, D'Agostino RB, Lee DS, Kannel WB, Benjamin EJ, Vasan RS (2014) Am J Cardiol 113: 117-22 Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines. Neilan TG, Coelho-Filho OR, Pena-Herrera D, Shah RV, Jerosch-Herold M, Francis SA, Moslehi J, Kwong RY (2012) Am J Cardiol 110: 1679-86 Prognostic effect of bundle branch block related to coronary artery bypass grafting. Chu A, Califf RM, Pryor DB, McKinnis RA, Harrell FE, Lee KL, Curtis SE, Oldham HN, Wagner GS (1987) Am J Cardiol 59: 798-803 Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy. Neilan TG, Coelho-Filho OR, Shah RV, Feng JH, Pena-Herrera D, Mandry D, Pierre-Mongeon F, Heydari B, Francis SA, Moslehi J, Kwong RY, Jerosch-Herold M (2013) Am J Cardiol 111: 717-22 Usefulness of biventricular volume as a predictor of mortality in patients with diabetes mellitus (from the Diabetes Heart Study). Cox AJ, Hugenschmidt CE, Wang PT, Hsu FC, Kenchaiah S, Daniel K, Langefeld CD, Freedman BI, Herrington DM, Carr JJ, Stacey B, Bowden DW (2013) Am J Cardiol 111: 1152-8
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.